MetLife reported nine-month net income available to common shareholders of $4.2 billion, up from $2.4 billion, and adjusted earnings available to common shareholders of $4.9 billion, up from $4.3 billion, for the nine months ended September 30, 2026.
Net income (loss) available to MetLife, Inc.’s common shareholders was $2.4 billion and $4.2 billion for the three months and nine months ended September 30, 2026, respectively, compared to $818 million and $2.4 billion for the three months and nine months ended September 30, 2025, respectively.Adjusted earnings available to common shareholders was $1.8 billion and $4.9 billion for the three months and nine months ended September 30, 2026, respectively, compared to $1.6 billion and $4.3 billion for the three months and nine months ended September 30, 2025, respectively.Open the document at this passage
MetLife delivered its highest adjusted EPS quarter ever: adjusted earnings of $1.8 billion and adjusted EPS of $2.85, up 22%, while adjusted ROE excluding notable items reached 19.6%. It repurchased $650 million of shares in the third quarter and another $265 million in October.
4 source passages
We delivered MetLife's highest adjusted earnings per share quarter ever with top-line growth across all operating segments.Excluding notable items, adjusted earnings were $1.8 billion, up 17%, and adjusted earnings per share were $2.85, up 22%, both from a year ago.Adjusted return on equity, excluding notable items, was 19.6%, well above our full year 15 to 17% target range.In the third quarter, we repurchased $650 million of our common shares. And another $265 million in October.Open the document at this passage
MetLife reported 3Q 2026 adjusted earnings of $1.8 billion, up 12%, and record adjusted earnings per share of $2.85 excluding notable items. Premiums, fees and other revenues rose 12% to $14.1 billion, while approximately $1 billion was returned to shareholders.
Financial results, Regulation FD disclosure, Other eventsRead from the first part of this long document5 source passages
MetLife Announces 3Q 2026 Results•Adjusted earnings increased 12% to $1.8 billion, driven by higher variable investment income, broad-based volume growth and favorable underwriting.•Adjusted earnings per share up 22% to $2.85, excluding total notable items — highest-ever quarter for MetLife.•Premiums, fees and other revenues (PFOs) increased 12% to $14.1 billion.•Returned approximately $1 billion to shareholders via share repurchases and common stock dividends.Open the document at this passage
MetLife estimates variable investment income of at least $600 million (pre-tax) for the quarter ended September 30, 2026, versus full-year 2026 guidance of approximately $1.6 billion (pre-tax).
820 of 1,467 funds reported for Sep 30 · net -402.5K sh shares · +76 new
Insider flowFlat
No net insider activity over 90 days
Short interestFalling
1.71% of shares out · ▼ -4.0% MoM · 3.3 days cover
Volume signalNormal
Volume near normal
Institution breadthMulti-yr high
1,467 holders — near 3-yr high, broad support
Squeeze score58
elevated · 0–100
Fundamentals
Strong
Revenue growth+9%
Y/Y
EPS growth−21%
Y/Y
ValuationP/E 13.1
in line
Buyback$3.0B
remaining
Balance sheet$7.2B
net cash
Quant / Vol
risk profile
Low
Volatility24%
annualized · 1-yr
Max drawdown−18%
past year
ATR2.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
what management promised — and delivered
Latest guidance
· from the Earnings Call filed Aug 6, 2026
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
MetLife reported nine-month net income available to common shareholders of $4.2 billion, up from $2.4 billion, and adjusted earnings available to common shareholders of $4.9 billion, up from $4.3 billion, for the nine months ended September 30, 2026.
Dividends per share over the trailing 365 days by ex-date · buyback figures as last
reported in SEC filings ("spent" derived as authorized − remaining; when several
programs run concurrently, authorized is their combined total per the newest filing) ·
components shown separately — trailing-year buyback spend isn't tracked, so no
combined shareholder yield is derived.
